Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-02

Study Completion Date

2021-01-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Compliance of Diabetic Patients Treated With Metformin

NCT03864705

Type 2 Diabetes Mellitus

UNKNOWN

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

NCT00543361

Diabetes Mellitus, Type 2

TERMINATED PHASE3

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

NCT01037842

Type 2 Diabetes

COMPLETED PHASE3

Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects

NCT00857870

Type 2 Diabetes

COMPLETED PHASE4

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

NCT03593707

Healthy Volunteers

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Type 2 Diabetes

Patients with Metformin containing prescription drugs will be eligible for participation and consecutively invited to study participation in their pharmacy.

No intervention

Intervention Type OTHER

Completing questionnaires via ePRO app from their own mobile devices

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Completing questionnaires via ePRO app from their own mobile devices

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult female or male patient
* Valid prescription for a Metformin containing drug approved in Germany
* Decision to initiate treatment with Metformin was made by the treating physician as part of the routine treatment practice
* Signed informed consent